Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient (API) business by Matrix Laboratories founder Nimmagadda Prasad. The investment was made through Kotak Strategic Situations Fund II, as stated in a news release on Tuesday. However, specific details regarding the funding structure were not disclosed.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.